Search
News
Qnity Q2 2026 earnings: Revenue rises 22% as GAAP profit falls
Qnity’s Q2 2026 net sales rose 22% year over year to $1.429 billion, while GAAP diluted EPS declined 34% to $0.59. Adjusted EPS increased 53% to $1.19 and adjusted operating EBITDA rose 24% to $431 million, as Interconnect Solutions grew 30% and Semiconductor Technologies grew 16%. Higher interest expense, transformation charges and other costs weighed on GAAP profit despite higher gross profit. Qnity also raised full-year 2026 guidance, including net sales of $5.55 billion to $5.65 billion and adjusted free cash flow of $600 million to $700 million.
TradingKey
Wed, Aug 5
Gartner Q2 2026 Earnings: EPS Rises 33.1% as Adjusted Revenue Grows 2.8%
Gartner’s Q2 2026 revenue declined 0.6% to $1.676 billion, but adjusted revenue excluding the divested Digital Markets operation rose 2.8%. GAAP diluted EPS increased 33.1% to $4.14, supported by 14.4% net income growth and a lower diluted share count. Free cash flow advanced 8.9% to $378 million. Operating income also increased about 15.7%, lifting the GAAP operating margin. Conferences grew 15.5%, Insights rose 2.1%, and Consulting fell 8.8%, while FX-neutral contract value increased 1.7% year over year.
TradingKey
Wed, Aug 5
Sequans Q2 2026 earnings: Product sales rise as gross margin contracts
Sequans Communications’ preliminary Q2 2026 results showed revenue of $7.5 million, down 8.4% year over year, while product sales rose 83.7%. Gross margin fell to 32.9% from 64.4% because the prior-year period benefited from Qualcomm license and services revenue and the current mix shifted toward products. The IFRS net loss widened to $9.8 million, although diluted loss per ADS narrowed to $0.65. Cash reached $21.0 million after Bitcoin sales helped fund the full redemption of convertible debt, while first-half operating cash outflow increased to $23.0 million.TradingKey
Wed, Aug 5
IDEAYA Q2 2026 earnings: Darovasertib NDA advances with $1.24 billion in cash
IDEAYA Biosciences’ Q2 2026 collaboration revenue rose sequentially to $8.9 million from $6.6 million, while net loss widened to $112.5 million as R&D and commercial-preparation costs increased. Cash, cash equivalents and marketable securities reached approximately $1.24 billion after June equity financing, supporting unchanged runway guidance into 2030. The main operating milestone was OptimUM-02’s positive progression-free survival result for the darovasertib combination, with an NDA submission underway through the FDA’s real-time oncology review program and several pipeline updates planned for the second half of 2026.
TradingKey
Wed, Aug 5
Leidos Q2 FY2026 Earnings: Revenue Rises as Margins Narrow
Leidos reported Q2 FY2026 revenue of $4.56 billion, up 7% year over year, while GAAP diluted EPS fell to $2.81 from $3.01. Adjusted EBITDA declined 2% to $631 million and its margin narrowed to 13.8%, but operating cash flow rose to $793 million and free cash flow reached $761 million. Homeland led segment growth, while lower medical disability exam volumes weighed on Health. Leidos also raised the low ends of its FY2026 revenue and non-GAAP EPS ranges and increased its operating cash flow outlook to approximately $1.85 billion.
TradingKey
Wed, Aug 5
Eve Q2 2026 earnings: Lower R&D narrows the net loss
Eve Holding’s Q2 2026 results showed a net loss of $34.2 million, down from $64.7 million a year earlier, as R&D expense fell to $28.9 million from $45.7 million. Quarterly cash consumption declined to $49.4 million, partly because some Embraer-related payments moved into Q3. Eve ended the quarter with $403.3 million in cash, cash equivalents and financial investments, while total liquidity reached $531.3 million. The pre-operational eVTOL developer expects full-year 2026 cash consumption of $250 million.TradingKey
Wed, Aug 5
Ball Q2 2026 Earnings: Shipments Rise as Operating Margin Narrows
Ball Corporation’s Q2 2026 revenue rose about 19.7% to $3.997 billion, comparable diluted EPS increased 14.4% to $1.03, and global aluminum packaging shipments grew 4.3%. Profit growth trailed sales as metal-linked pass-through pricing expanded revenue while North American operating and plant startup costs weighed on margins. South America delivered the largest regional earnings increase. Ball reiterated its 2026 goals, but negative first-half free cash flow means second-half cash conversion will be central to achieving the full-year target, while leverage has also increased from year-end.
TradingKey
Wed, Aug 5
DuPont Q2 2026 earnings: Adjusted EPS rises 48% on 4% sales growth
DuPont (NYSE: DD) reported second-quarter 2026 net sales of $1.819 billion, up 4% year over year, while adjusted EPS rose 48% to $1.88. Operating EBITDA increased 6% to $448 million and margin expanded 40 basis points to 24.6%, supported by organic growth and productivity. Continuing-operations cash flow also improved, with $400 million from operations and $326 million of transaction-adjusted free cash flow. The company raised full-year operating EBITDA and adjusted EPS guidance, citing strength in healthcare, industrial water and aerospace as support for its second-half outlook.
TradingKey
Wed, Aug 5
Waters Q2 2026 Earnings: Acquisition Doubles Revenue as GAAP Results Turn Negative
Waters' Q2 2026 revenue reached $1.645 billion, up 113% year over year after its Biosciences and Diagnostic Solutions acquisition, while organic revenue rose 7% reported and 9% in constant currency. The company posted a GAAP loss of $1.39 per share as acquisition-related amortization and fair-value step-ups weighed on reported earnings, but adjusted EPS increased 3% to $3.05. Operating cash flow improved to $200 million, and Waters raised full-year guidance to 7%-9% organic constant-currency growth and adjusted EPS of $14.45-$14.65 as end-market conditions broadened.
TradingKey
Wed, Aug 5
Wix Q2 2026 earnings: Revenue growth comes with weaker profitability
Wix.com’s Q2 2026 revenue rose 15% year over year to $563.1 million, while bookings increased 12% to $569.1 million. GAAP diluted EPS swung to a $1.78 loss from $0.98 in profit, and free cash flow fell to $52.6 million as operating expenses increased. Creative Subscriptions and Business Solutions revenue grew 15% and 14%, respectively. Wix maintained its full-year low- to mid-teens revenue growth outlook and expects Base44’s non-GAAP gross margin to reach about 60% in the second half as its proprietary AI model lowers compute costs.
TradingKey
Wed, Aug 5
FibroBiologics Q2 2026 Earnings: CYWC628 Dosing Begins With $3.5 Million in Cash
FibroBiologics (Nasdaq: FBLG) reported a Q2 2026 net loss of approximately $4.1 million, with R&D expense declining to $1.7 million from $2.0 million and G&A remaining about $2.4 million. Cash and equivalents totaled roughly $3.5 million at June 30. The quarter’s main operating development was the start of patient dosing in the Phase 1/2 CYWC628 diabetic foot ulcer trial. Interim results are targeted for the second half of 2026, while completed private and public financings provided additional capital and warrant exercises could generate up to approximately $6.0 million more.
TradingKey
Wed, Aug 5
CCEP H1 2026 results: Volume growth supports higher revenue
Coca-Cola Europacific Partners (CCEP) reported Q2 2026 revenue growth of 2.5% on a reported basis and 3.3% on an FX-neutral basis, with days-adjusted volume up 3.2%. For the six months ended July 3, 2026, reported revenue increased 4.4%, FX-neutral revenue rose 6.1%, and adjusted volume grew 2.2%. APS volume outpaced Europe, while water, sports, ready-to-drink tea and coffee, and energy-related categories led growth. Management cited continued margin expansion from efficiencies, reaffirmed full-year guidance, and flagged consumer, Middle East, and currency uncertainty.
TradingKey
Wed, Aug 5
Mohawk Industries Q2 2026 earnings: Tariff reimbursements amplify margin gains
Mohawk Industries’ Q2 fiscal 2026 net sales rose 6.8% to $2.99 billion, while GAAP diluted EPS increased to $3.22 from $2.34 and adjusted EPS reached $3.67. Adjusted operating margin expanded to 9.7% from 8.0%, supported by volume, pricing, mix, productivity and about $0.63 per share of tariff reimbursements. Free cash flow increased to $228.2 million. The company guided Q3 adjusted EPS to $2.50-$2.60, including roughly $0.12 of additional tariff reimbursements, as weak residential demand and higher input costs remain key pressures.
TradingKey
Wed, Aug 5
Mohawk Q2 2026 earnings: Profit rises with tariff refund support
Mohawk Industries’ Q2 2026 net sales rose 6.8% to $2.99 billion, while diluted EPS increased to $3.22 from $2.34 and adjusted EPS reached $3.67. The quarter included about $0.63 per share of tariff refunds, making that benefit important to the profit comparison. Free cash flow climbed to $228.2 million, and adjusted operating margin expanded to 9.7% from 8.0%. Global Ceramic and Flooring Rest of World posted adjusted sales growth, while Flooring North America declined 4.7% on an adjusted basis. Q3 baseline EPS guidance is $2.38 to $2.48.TradingKey
Wed, Aug 5
Iradimed Q2 2026 earnings: 3870 pump transition compresses margins
Iradimed reported Q2 2026 revenue of $20.5 million, up 0.5% year over year, while GAAP diluted EPS fell 9% to $0.41 and gross margin declined to 74% from 78%. The launch and production ramp of the new 3870 MRI-compatible IV pump weighed on pump revenue and manufacturing efficiency, even as patient-monitor, disposables, and ferromagnetic-detection sales increased. Operating cash flow fell 23% to $5.9 million, but free cash flow rose to $5.5 million as capital spending dropped. Management reaffirmed full-year 2026 revenue and EPS guidance.
TradingKey
Wed, Aug 5
GCL Fiscal 2026 Earnings: Revenue Growth Came With Margin Compression
GCL Global Holdings’ fiscal 2026 revenue rose 68.2% to US$238.9 million, but gross margin fell to 10.3% from 15.0% as lower-margin distribution represented more of the expanded business. The company recorded a US$26.2 million net loss and a US$0.20 loss per share, reversing the prior-year profit, while non-GAAP EBITDA swung to a US$18.9 million loss. Cash increased to US$36.6 million, alongside higher inventory and US$54.0 million of bank borrowings tied to acquisitions and the larger operating platform.TradingKey
Wed, Aug 5
Colgate-Palmolive Q2 2026 Earnings: Gross Margin Expands as GAAP EPS Falls
Colgate-Palmolive’s Q2 2026 net sales rose 4.9% to $5.36 billion, while organic sales increased 2.4%. GAAP diluted EPS fell 5% to $0.86, but Base Business EPS advanced 8% to $0.99. Gross margin expanded 140 basis points to 61.5%, although higher SG&A and other expenses reduced GAAP operating margin to 19.0%. Latin America led divisional growth, while North America declined and Hill’s volumes remained under pressure. The company maintained its sales and GAAP EPS outlook while improving full-year gross-margin and Base Business EPS guidance.
TradingKey
Wed, Aug 5
Church & Dwight Q2 2026 earnings: Organic growth supports raised guidance
Church & Dwight’s Q2 2026 net sales increased 1.6% to $1.53 billion, while organic sales grew 5.8% on 4.3% volume growth and 1.5% favorable price and mix. Diluted EPS rose to $0.85 from $0.78, but adjusted EPS fell to $0.89 as higher marketing and acquisition-related SG&A absorbed gross-margin gains. International organic sales led the divisions at 9.1%. The company raised full-year organic sales growth guidance to 4%-5% and operating cash flow guidance to approximately $1.175 billion.
TradingKey
Wed, Aug 5
AutoNation Q2 2026 earnings: Buybacks support EPS as vehicle profits decline
AutoNation’s Q2 2026 revenue slipped 0.6% to $6.93 billion, while GAAP diluted EPS rose to $5.39 from $2.26 and adjusted EPS increased 2% to $5.56. Total gross profit fell 3.5% and adjusted operating income declined 7% as lower vehicle volumes and margins outweighed gains in after-sales and AutoNation Finance. A 12% lower diluted share count supported per-share results. First-half adjusted free cash flow was $439.2 million, while the company spent $457 million on buybacks and added dealerships representing about $600 million in annual revenue.
TradingKey
Wed, Aug 5
LyondellBasell Q2 2026 Earnings: Supply Tightness Expands Polymer Margins
LyondellBasell (NYSE: LYB) reported Q2 2026 revenue of $9.18 billion, up about 20% from $7.66 billion a year earlier, while diluted EPS rose to $1.71 from $0.34. Net income reached $559 million, and EBITDA excluding identified items was $2.13 billion as supply disruptions improved polymer margins and co-product pricing. GAAP earnings absorbed $842 million of after-tax identified items, led by the European asset divestiture. Operating cash flow totaled $752 million despite working-capital use, and LYB expects lower Q3 operating rates across its O&P and I&D assets.
TradingKey
Wed, Aug 5
Featured Tools
Top News
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth
Meta Q3 2026 Earnings Call: Ad Growth, Muse AI and Q4 Guidance